Page last updated: 2024-08-16

pindolol and ephedrine

pindolol has been researched along with ephedrine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caron, G; Ermondi, G1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Gozalbes, R; Pineda-Lucena, A1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Molinoff, PB; Neve, KA1
Molinoff, PB1
Aarons, RD; Molinoff, PB1

Reviews

3 review(s) available for pindolol and ephedrine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation.
    Drugs, 1984, Volume: 28 Suppl 2

    Topics: Calcium; Catecholamines; Cyclic AMP; Ephedrine; Humans; Phosphatidylinositols; Pindolol; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Terbutaline

1984
Effects of drugs on beta-adrenergic receptors on human lymphocytes.
    Journal of cardiovascular pharmacology, 1983, Volume: 5 Suppl 1

    Topics: Adult; Animals; Ephedrine; Humans; Lymphocytes; Pindolol; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Terbutaline

1983

Trials

1 trial(s) available for pindolol and ephedrine

ArticleYear
Effects of drugs on beta-adrenergic receptors on human lymphocytes.
    Journal of cardiovascular pharmacology, 1983, Volume: 5 Suppl 1

    Topics: Adult; Animals; Ephedrine; Humans; Lymphocytes; Pindolol; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Terbutaline

1983

Other Studies

5 other study(ies) available for pindolol and ephedrine

ArticleYear
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
    Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9

    Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water

2005
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.
    The American journal of cardiology, 1986, Apr-25, Volume: 57, Issue:12

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Celiprolol; Cells, Cultured; Ephedrine; Heart; Humans; Leukocytes; Pindolol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta; Terbutaline

1986